Cargando…
Projected COVID-19 Mortality Reduction From Paxlovid Rollout
This decision analytical model study assesses projections of simulated effects of Paxlovid rollout on hospitalizations and mortality using 10 models.
Autores principales: | Khunte, Mihir, Kumar, Soryan, Salomon, Joshua A., Bilinski, Alyssa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10024200/ https://www.ncbi.nlm.nih.gov/pubmed/36930169 http://dx.doi.org/10.1001/jamahealthforum.2023.0046 |
Ejemplares similares
-
Modeling Contact Tracing Strategies for COVID-19 in the Context of Relaxed Physical Distancing Measures
por: Bilinski, Alyssa, et al.
Publicado: (2020) -
Efficacy and safety of Paxlovid for COVID-19:a meta-analysis
por: Zheng, Qian, et al.
Publicado: (2023) -
The future of Paxlovid for COVID-19
por: Burki, Talha
Publicado: (2022) -
Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China
por: Zhang, Weina, et al.
Publicado: (2023) -
Efficacy of Paxlovid in patients with acute kidney injury who developed COVID-19
por: Cai, Hong, et al.
Publicado: (2022)